Gieffers Jens, Ahuja André, Giemulla Ronald
Institute of Microbiology, Hygiene and Laboratory Medicine, Klinikum Lippe, Detmold, Germany.
Department of Life Science Technologies, Hochschule Ostwestfalen-Lippe, University of Applied Sciences, Lemgo, Germany.
GMS Hyg Infect Control. 2016 Oct 5;11:Doc21. doi: 10.3205/dgkh000281. eCollection 2016.
Data on MRSA prevalence in rehabilitation centers are sparse. We screened more than 18,000 patients with neurological, cardiac/pulmonary or orthopedic diagnoses treated in three German rehabilitation centers and documented potential risk factors in almost 1,500 of them. 2.1% were MRSA positive (CI 1.9%-2.4%). Prevalence was higher in neurologic patients (3.7%) and lower in orthopedic patients (0.9%). While the overall MRSA situation was stable over two years, the weekly MRSA rate fluctuated strongly (0.0% to 8.0%). We confirmed five risk factors in our study population. A risk adapted screening strategy derived from our data had a significance of 74% and a positive predictive value of only 2.2%. MRSA positivity is a rare and highly variable event, requiring a huge sample size to generate robust data. The benefit of a risk-adapted screening strategy over a general screening should be questioned in each individual setting.
康复中心耐甲氧西林金黄色葡萄球菌(MRSA)感染率的数据很稀少。我们对德国三家康复中心治疗的18000多名患有神经、心脏/肺部或骨科疾病的患者进行了筛查,并记录了其中近1500名患者的潜在风险因素。2.1%的患者MRSA检测呈阳性(置信区间为1.9%-2.4%)。神经科患者的感染率较高(3.7%),骨科患者的感染率较低(0.9%)。虽然两年内MRSA的总体情况保持稳定,但每周的MRSA感染率波动很大(0.0%至8.0%)。我们在研究人群中确认了五个风险因素。根据我们的数据得出的风险适应性筛查策略的显著性为74%,阳性预测值仅为2.2%。MRSA阳性是一种罕见且高度可变的事件,需要大量样本才能得出可靠的数据。在每个具体情况下,都应质疑风险适应性筛查策略相对于常规筛查的益处。